Novo Nordisk | NVO - Ebit


Novo Nordisk reported DKK5.18B in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bausch Health Companies USD 719M 2M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Phibro Animal Health USD 26M 5.54M Sep/2024
Prestige Brands USD 82.49M 2.82M Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Zoetis USD 835M 140M Dec/2025